InBios International, Inc.
307 Westlake Ave. N., Suite 300
1 article with InBios International, Inc.
Curebase, InBios Announce Results of Virtual Clinical Trial of InBios COVID-19 Rapid Detection Test Using Curebase Platform
Curebase today announced that InBios successfully utilized Curebase's virtual site solution to power clinical studies for its SCoV-2 Ag Detect™ Rapid Test, which was granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) on May 6, 2021.